0001437749-23-030250.txt : 20231103 0001437749-23-030250.hdr.sgml : 20231103 20231103174133 ACCESSION NUMBER: 0001437749-23-030250 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20231023 FILED AS OF DATE: 20231103 DATE AS OF CHANGE: 20231103 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Danahy Kevin Patrick CENTRAL INDEX KEY: 0001913245 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37744 FILM NUMBER: 231377515 MAIL ADDRESS: STREET 1: 50 TEABERRY LANE CITY: BRAINTREE STATE: MA ZIP: 02184 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Pulse Biosciences, Inc. CENTRAL INDEX KEY: 0001625101 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 465696597 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 3957 POINT EDEN WAY CITY: HAYWARD STATE: CA ZIP: 94545 BUSINESS PHONE: 510-906-4600 MAIL ADDRESS: STREET 1: 3957 POINT EDEN WAY CITY: HAYWARD STATE: CA ZIP: 94545 FORMER COMPANY: FORMER CONFORMED NAME: Electroblate, Inc. DATE OF NAME CHANGE: 20141113 4 1 rdgdoc.xml FORM 4 X0508 4 2023-10-23 0001625101 Pulse Biosciences, Inc. PLSE 0001913245 Danahy Kevin Patrick C/O PULSE BIOSCIENCES, INC. 3957 POINT EDEN WAY HAYWARD CA 94545 1 Chief Executive Officer 0 Stock Option (right to buy) 3.96 2023-10-23 4 A 0 130000 0 A 2033-10-23 Common Stock 130000 130000 D Stock Option (right to buy) 3.96 2023-11-01 4 J 0 130000 0 D 2033-10-23 Common Stock 130000 0 D Stock Option (right to buy) 4.38 2023-11-01 4 A 0 460000 0 A 2033-11-01 Common Stock 460000 460000 D The shares will vest in four equal annual installments on each of the first four annual anniversaries of the grant date, subject to the Reporting Person's continued service through each vesting date. Reporting Person was erroneously granted an option to acquire 130,000 shares on October 23, 2023, which option was cancelled by mutual agreement on November 1, 2023. 100% vesting upon the earlier of (i) the six (6) year anniversary of the grant date, and (ii) the 1-year anniversary of a Company change of control. /s/ Kenneth B. Stratton, as Attorney-in-Fact 2023-11-03